Warning! GuruFocus detected
1 Medium warning sign
with 0NM7.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Virbac SA
ISIN : FR0000031577
Compare
Compare
Traded in other countries / regions
VIRP.France0NM7.UKVRBCF.USAV16.Germany IPO Date
2008-01-09Description
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by Asia and Latin America.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.49 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.29 | |||||
| Debt-to-EBITDA | 1.1 | |||||
| Interest Coverage | 20.53 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.41 | |||||
| Beneish M-Score | -2.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.9 | |||||
| 3-Year EBITDA Growth Rate | 10.2 | |||||
| 3-Year EPS without NRI Growth Rate | 9.5 | |||||
| 3-Year FCF Growth Rate | 14.7 | |||||
| 3-Year Book Growth Rate | 13.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 8.57 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.39 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.6 | |||||
| 9-Day RSI | 44.2 | |||||
| 14-Day RSI | 45.52 | |||||
| 3-1 Month Momentum % | 0.32 | |||||
| 6-1 Month Momentum % | -20.46 | |||||
| 12-1 Month Momentum % | -8.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.82 | |||||
| Quick Ratio | 0.95 | |||||
| Cash Ratio | 0.32 | |||||
| Days Inventory | 304.57 | |||||
| Days Sales Outstanding | 51.08 | |||||
| Days Payable | 125.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.44 | |||||
| Dividend Payout Ratio | 0.07 | |||||
| 3-Year Dividend Growth Rate | 20.7 | |||||
| Forward Dividend Yield % | 0.44 | |||||
| 5-Year Yield-on-Cost % | 0.44 | |||||
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | -7.88 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.1 | |||||
| Operating Margin % | 16.34 | |||||
| Net Margin % | 10.4 | |||||
| FCF Margin % | 8.86 | |||||
| ROE % | 14.84 | |||||
| ROA % | 8.55 | |||||
| ROIC % | 13.45 | |||||
| 3-Year ROIIC % | 6.55 | |||||
| ROC (Joel Greenblatt) % | 35.12 | |||||
| ROCE % | 17.72 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.3 | |||||
| Forward PE Ratio | 15.68 | |||||
| PE Ratio without NRI | 16.08 | |||||
| Shiller PE Ratio | 31.83 | |||||
| Price-to-Owner-Earnings | 18.44 | |||||
| PEG Ratio | 1.87 | |||||
| PS Ratio | 1.8 | |||||
| PB Ratio | 2.4 | |||||
| Price-to-Tangible-Book | 4.93 | |||||
| Price-to-Free-Cash-Flow | 20.28 | |||||
| Price-to-Operating-Cash-Flow | 12.3 | |||||
| EV-to-EBIT | 12.31 | |||||
| EV-to-EBITDA | 9.69 | |||||
| EV-to-Revenue | 1.93 | |||||
| EV-to-FCF | 21.94 | |||||
| Price-to-GF-Value | 0.78 | |||||
| Price-to-Projected-FCF | 1.34 | |||||
| Price-to-DCF (Earnings Based) | 0.47 | |||||
| Price-to-DCF (FCF Based) | 0.81 | |||||
| Price-to-Median-PS-Value | 0.95 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.91 | |||||
| Price-to-Graham-Number | 1.89 | |||||
| Price-to-Net-Current-Asset-Value | 65.62 | |||||
| Earnings Yield (Greenblatt) % | 8.12 | |||||
| FCF Yield % | 4.88 | |||||
| Forward Rate of Return (Yacktman) % | 11.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Virbac SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,397.379 | ||
| EPS (TTM) (€) | 17.33 | ||
| Beta | 1.11 | ||
| 3-Year Sharpe Ratio | -0.17 | ||
| 3-Year Sortino Ratio | -0.24 | ||
| Volatility % | 31.94 | ||
| 14-Day RSI | 45.52 | ||
| 14-Day ATR (€) | 8.084649 | ||
| 20-Day SMA (€) | 306.8125 | ||
| 12-1 Month Momentum % | -8.73 | ||
| 52-Week Range (€) | 290.5 - 399 | ||
| Shares Outstanding (Mil) | 8.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Virbac SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Virbac SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Virbac SA Frequently Asked Questions
What is Virbac SA(LTS:0NM7)'s stock price today?
The current price of LTS:0NM7 is €302.50. The 52 week high of LTS:0NM7 is €399.00 and 52 week low is €290.50.
When is next earnings date of Virbac SA(LTS:0NM7)?
The next earnings date of Virbac SA(LTS:0NM7) is .
Does Virbac SA(LTS:0NM7) pay dividends? If so, how much?
The Dividend Yield %  of Virbac SA(LTS:0NM7) is 0.44% (As of Today), Highest Dividend Payout Ratio of Virbac SA(LTS:0NM7) was 1.93. The lowest was 0.05. And the median was 0.08. The  Forward Dividend Yield % of Virbac SA(LTS:0NM7) is 0.44%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers